4.7 Article

A Combination of an Angiotensin II Receptor and a Neprilysin Inhibitor Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cell Biology

Neprilysin-dependent neuropeptide Y cleavage in the liver promotes fibrosis by blocking NPY-receptor 1

Cristina Ortiz et al.

Summary: The development of liver fibrosis is associated with the contraction of hepatic stellate cells (HSC), but the interaction between neprilysin (NEP) and its substrate neuropeptide Y (NPY) in liver fibrosis is not well understood.NEP is derived from HSCs while NPY mainly comes from the splanchnic region and is cleaved by NEP to terminate contraction. NEP deficiency leads to less fibrosis but portal hypertension in mice models of liver injury. Combining NEP inhibitor with angiotensin II type 1 receptor blocker (ARB) or ACE inhibitor provides incremental benefits for fibrosis and portal hypertension. Administration of Entresto, a combination of ARB and NEP inhibitor, reduces hepatic fibrosis and portal pressure in mice.

CELL REPORTS (2023)

Review Cardiac & Cardiovascular Systems

Natriuretic peptide pathways in heart failure: further therapeutic possibilities

S. Jeson Sangaralingham et al.

Summary: The discovery of the heart as an endocrine organ and the function of natriuretic peptides in cardiovascular, endocrine, renal, and metabolic actions have important implications for the treatment of heart failure. Understanding the biology and genetic variants of ANP and BNP, as well as the development of novel designer NPs and small molecules, provides new therapeutic opportunities.

CARDIOVASCULAR RESEARCH (2023)

Review Gastroenterology & Hepatology

Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Kuei-Chua Lee et al.

Summary: The initial presentation of non-alcoholic steatohepatitis (NASH) is hepatic steatosis, which is caused by dysfunction of lipid metabolism within hepatocytes. Lipotoxicity, oxidative stress, mitochondrial dysfunction, and endoplasmic reticulum stress further contribute to hepatic injury and inflammation. Dysregulation of the gut-liver axis, adipose-liver axis, and renin-angiotensin system (RAS) may impair the development of NASH and liver fibrosis. Treatment options include lifestyle modification, pharmacological therapy, and non-pharmacological therapy.

CLINICAL AND MOLECULAR HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Angiotensin receptor blocker alleviates liver fibrosis by altering the mechanotransduction properties of hepatic stellate cells

Zisheng Huang et al.

Summary: Our study found that low-dose losartan can alleviate liver fibrosis by modulating the mechanotransduction properties of hepatic stellate cells.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2022)

Review Gastroenterology & Hepatology

New clinical and pathophysiological perspectives defining the trajectory of cirrhosis

Rajiv Jalan et al.

Summary: Traditionally, complications of cirrhosis were thought to be primarily caused by circulatory dysfunction due to portal hypertension; however, recent studies have shown that systemic inflammation and organ immunopathology play crucial roles in organ dysfunction in cirrhosis, impacting various organ systems. The interaction between traditional and emerging concepts in the initiation and maintenance of organ dysfunction in cirrhosis is a topic of great interest for future research.

JOURNAL OF HEPATOLOGY (2021)

Article Peripheral Vascular Disease

Angiotensin Receptor Blocker and Neprilysin Inhibitor Suppresses Cardiac Dysfunction by Accelerating Myocardial Angiogenesis in Apolipoprotein E-Knockout Mice Fed a High-Fat Diet

Yasunori Suematsu et al.

Summary: The study demonstrated that valsartan plus sacubitril can promote myocardial angiogenesis and improve cardiac function, indicating potential cardioprotective effects in early-stage cardiac dysfunction.

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2021)

Article Pharmacology & Pharmacy

Lcz696 Alleviates Myocardial Fibrosis After Myocardial Infarction Through the sFRP-1/Wnt/β-Catenin Signaling Pathway

Jing Liu et al.

Summary: The study demonstrated that ARNI alleviated myocardial fibrosis by inhibiting the Wnt/beta-catenin signaling pathway and overexpressing sFRP-1, thereby improving cardiac function.

FRONTIERS IN PHARMACOLOGY (2021)

Article Biotechnology & Applied Microbiology

The angiotensin-converting enzyme inhibitor, captopril, suppressed hepatic stellate cell activation via NF-kappaB or wnt3α/β-catenin pathway

Zhaodi Gu et al.

Summary: The study revealed that captopril effectively inhibits oxidative stress, inflammation, and fibrogenesis processes in HG-induced HSC-T6 cells.

BIOENGINEERED (2021)

Article Physiology

Sacubitril/valsartan treatment has differential effects in modulating diabetic kidney disease in db/db mice and KKAy mice compared with valsartan treatment

Komuraiah Myakala et al.

Summary: The combination drug sacubitril/valsartan shows potential therapeutic effects in diabetic kidney disease by attenuating proteinuria, glomerulosclerosis, and podocyte loss, and exerting renal protection through antioxidative stress and anti-inflammation. It also targets a new mechanism of inflammation in diabetic kidneys, the self-DNA-activated cGMP-AMP synthase-stimulator of interferon genes signaling, to prevent pathophysiological effects.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2021)

Review Cardiac & Cardiovascular Systems

Cardiac natriuretic peptides

Jens P. Goetze et al.

NATURE REVIEWS CARDIOLOGY (2020)

Article Gastroenterology & Hepatology

Portal Hypertension Pathogenesis and Diagnosis

Laura Turco et al.

CLINICS IN LIVER DISEASE (2019)

Article Biochemistry & Molecular Biology

17?-Estradiol nongenomically induces vascular endothelial H2S release by promoting phosphorylation of cystathionine ?-lyase

Xingyan Xu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Article Endocrinology & Metabolism

cGMP-dependent protein kinase I (cGKI) modulates human hepatic stellate cell activation

Andras Franko et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2018)

Review Gastroenterology & Hepatology

Mechanisms of hepatic stellate cell activation

Takuma Tsuchida et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)

Article Gastroenterology & Hepatology

Pathobiology of liver fibrosis: a translational success story

Youngmin A. Lee et al.

Article Medicine, General & Internal

Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure

John J. V. McMurray et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Review Gastroenterology & Hepatology

Fibrosis-dependent mechanisms of hepatocarcinogenesis

David Y. Zhang et al.

HEPATOLOGY (2012)

Review Medicine, Research & Experimental

The role of the renin-angiotensin system in liver fibrosis

M. Kamruzzman Munshi et al.

EXPERIMENTAL BIOLOGY AND MEDICINE (2011)

Review Biochemistry & Molecular Biology

Natriuretic peptide metabolism, clearance and degradation

Lincoln R. Potter

FEBS JOURNAL (2011)

Article Multidisciplinary Sciences

A cardiac pathway of cyclic GMP-independent signaling of guanylyl cyclase A, the receptor for atrial natriuretic peptide

Michael Klaiber et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Biochemistry & Molecular Biology

Continuos intravenous infusion of atrial natriuretic peptide(ANP) prevented liver fibrosis in rat

Noriko Ishigaki et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)

Review Biochemistry & Molecular Biology

Liver fibrogenesis: A new role for the renin-angiotensin system

R Bataller et al.

ANTIOXIDANTS & REDOX SIGNALING (2005)

Article Gastroenterology & Hepatology

Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver

R Bataller et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2003)

Review Gastroenterology & Hepatology

Liver fibrosis - from bench to bedside

SL Friedman

JOURNAL OF HEPATOLOGY (2003)

Article Gastroenterology & Hepatology

Angiotensin II induces contraction and proliferation of human hepatic stellate cells

R Bataller et al.

GASTROENTEROLOGY (2000)